Vaxelis Interactions
There are 305 drugs known to interact with Vaxelis (diphtheria toxoid/haemophilus b conjugate (prp-omp) vaccine/hepatitis b pediatric vaccine/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid), along with 6 disease interactions. Of the total drug interactions, 1 is major, 301 are moderate, and 3 are minor.
- View all 305 medications that may interact with Vaxelis
- View Vaxelis disease interactions (6)
Most frequently checked interactions
View interaction reports for Vaxelis (diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid) and the medicines listed below.
- Augmentin (amoxicillin / clavulanate)
- cetirizine
- Depo-Medrol (methylprednisolone)
- Kenalog-40 (triamcinolone)
- meningococcal polysaccharide vaccine
- methylphenidate
- naloxone
- oxycodone
- Percocet 5 / 325 (acetaminophen / oxycodone)
- Toradol IM (ketorolac)
- tramadol
- Vaxneuvance (pneumococcal 15-valent conjugate vaccine)
- Vyvanse (lisdexamfetamine)
Vaxelis disease interactions
There are 6 disease interactions with Vaxelis (diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid) which include:
Report options
More about Vaxelis (diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- Vaxelis consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: vaccine combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.